Poland· PL-100009890

Betadrin

A naphazolin, kombinationen product containing diphenhydramini hydrochloridum + naphazolini nitras, registered in Poland by Warszawskie Zakłady Farmaceutyczne POLFA S.A.. The same ATC class is registered in 6 of our 19 countries.

ATC S01GA51

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedBetadrinATCS01GA51REGISTER NO.PL-100009890PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Naphazolin, kombinationen is registered in 6 of 19 countries.

Countries holding a registration under ATC S01GA51 (naphazolin, kombinationen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose

Naphazolin, kombinationen · ATC S01GA51

6 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Ireland
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Diphenhydramini hydrochloridum + Naphazolini nitras
Manufacturer
Warszawskie Zakłady Farmaceutyczne POLFA S.A.
Country
Poland (PL)
ATC code
S01GA51
ATC class
Naphazolin, Kombinationen
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990181919
  • gtin
    05909990181926

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under S01GA51

Naphazolin, kombinationen, as other registers publish it.

All naphazolin, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Austria · Coldistan, Luuf Naphazolin Compositum

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9f172db8-b8c1-4814-bf47-b4231249bc8e
GET /v1/drugs/9f172db8-b8c1-4814-bf47-b4231249bc8e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krople do oczu, roztwór",
  "source": "urpl",
  "strength": "(1 mg + 0,33 mg)/ml",
  "packaging": "Rp ¦ Skasowane ¦ 1857\n1 fl. 10 ml\n05909990181919 ¦ Rp ¦ Skasowane ¦ 1860\n1 fl. 5 ml\n05909990181926 ¦ Rp ¦ 13423\n2 butelki 5 ml",
  "substance": "Diphenhydramini hydrochloridum 1 mg/ml + Naphazolini nitras 0.33 mg/ml",
  "common_name": "Diphenhydramini hydrochloridum + Naphazolini nitras",
  "pl_product_id": "100009890",
  "pozwolenie_nr": "01819",
  "auth_procedure": "NAR",
  "authorisation_validity": "2023-12-28"
}

See everything about naphazolin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.